IDBI Capital
Stories By IDBI Capital
Lemon Tree: IDBI Capital Sees Up To 37% Upside On Strong Q2 Earnings; Check Target PriceThe brokerage continues to like Lemon Tree amongst the mid-scale hotels segment given its scale of operations and better operating margin compared to other mid-scale hotels.
From Navin Fluorine To GE Vernova Q2 Results Review: Check IDBI Capital's Revised Target PricesIDBI Capital remained positive on stocks across the power equipment, specialty chemicals and industrial capital goods sectors including Navin Fluorine, Ador Welding, Acutaas and GE Vernova after reviewing their Q2FY27 performance, reiterating Buy ratings on the four stocks.
PVR-INOX Q2 Review: Best-Ever Quarter Keeps IDBI Capital Bullish; Check Target PriceThe brokerage sees the SMART Cinema pilot as strategically important for PVR-INOX with 2530% lower capex, about 25% ower operating cost, and Rs 190 average ticket pricing create a credible format for underpenetrated tier-3/4 markets.
IndusInd Bank Shares: IDBI Capital Stays Bullish After Strong Q2 Performance; Check Target PriceManagement targets growth in line with the market and remains on track for 1% exit RoA in FY27, with a medium-term ambition of 1.751.80%, adds the brokerage.
L&T Tech Q2 Review: IDBI Capital Upgrades Rating But Trims Target Price Despite Earnings Beat; Here's WhyL&T Tech's Ebit margin of 16.3% rose 60 basis points QoQ and 220 bps YoY, with all segments expanding, so the mid-16% aspiration arrived two quarters early, adds the brokerage.
HDFC Bank Q2 Review: Five Brokerages Stay Bullish, Sees Up To 37% Upside; Check Target PricesWhile Nirmal Bang is the most optimistic among the five brokerages, with a target price of Rs 1,000, Anand Rathi and ICICI Securities have placed greater emphasis on the time required for a sustained post-merger recovery.
Axis Bank Q2 Review: ICICI Securities Sees Up To 26% Upside; Check Other Brokerages Target Prices, RatingsThe three brokerages, ICICI Securities, IDBI Capital, Systematix remain positive on Axis Bank despite pressure on margins and operating expenses during the September quarter. The private lender reported a 37.6% YoY increase in net profit to Rs 7,003 crore, supported by lower provisions.
ICICI Bank Q2 Review: FCNR Gains Boost Balance Sheet, Says IDBI Capital; Check Target PriceExcluding Foreign Currency Non-Resident (Bank), ICICI Bank's loan and deposit growth stood at 24.1% and 17.0% YoY, respectively, with the FCNR(B) window contributing 10%t to deposit growth, adds the brokerage.
HCLTech Q2 Review: IDBI Capital Sees 13% Upside As AI-Led Mix Lifts Margins; Guidance Looks ConservativeThe brokerage highlighted that HCLTech delivered one of its cleanest quarters in a while, revenue of $3,724 million grew 2.3% QoQ and 2.6% YoY in constant currency, with services up 3% QoQ and 4% YoY
TCS Q2 Review: Demand Is Not The Problem, Margins Are, Says IDBI Capital, Maintains 'Buy'; Check Target PriceTCS's Ebit margin remained stable at 24.0% QoQ despite higher investments in strategic partnerships, M&A initiatives, niche talent, higher bench and subcontractors, with currency gains and operating leverage partly offsetting the headwinds, adds the brokerage.
IT Q2 Results Preview: A Quiet Quarter Ahead; TCS Among IDBI Capital's Preferred Large-Cap PicksMid-tier IT companies are expected to outgrow their larger peers, although the brokerage cautioned that acquisitions are boosting headline growth at some companies, making the quality and sustainability of growth an important factor to watch.
Astral Q1 Review: Profit Surges 52%; IDBI Capital Maintains 'Buy' — Check Target PriceAstral expects double-digit plumbing growth with 16%18% Ebitda margins, alongside 15%20% growth guidance for adhesives, adds the brokerage.
Surya Roshni, Ddev Plastiks, Harsha Engineers, BLS International In Focus After Q1 Review: Check IDBI Capital's Ratings, Target PricesIDBI Capital retained Hold on Surya Roshni with a target price of Rs 225, downgraded Ddev Plastiks to Hold from Buy.
Lemon Tree Hotels Shares May Rally 46%, Says IDBI Capital After Q1 Results — Check Target PriceDespite temporary weakness in corporate travel, Lemon Tree Hotels delivered steady Q1 growth, expanded its portfolio, and remains well positioned to benefit from strong demand in India's mid-market hospitality segment.
Finolex Industries Q1 Review: IDBI Capital Cuts Estimates, Sees Volume Growth Headwinds — Check Revised Target PriceFinolex Industries' sales volumes fell 27% in Q1 FY27 amid PVC market volatility, prompting IDBI Capital to cut earnings estimates and maintain a Hold rating.
Navin Fluorine Goes From Strength To Strength, Says IDBI Capital After Q1 Beat — Check Revised Target PriceNavin Fluorine International remained in focus after IDBI Capital said the specialty chemicals maker is well-positioned for future growth, driven by robust momentum across its High Performance Products (HPP), Specialty Chemicals and CDMO businesses.
Muthoot Finance Q1 Review: Strong AUM Growth Keeps IDBI Capital Bullish — Check Target PriceMuthoot Finance reported a strong Q1 with consolidated assets under management rising 43% YoY to Rs 1.92 trillion, while standalone gold loan AUM grew 44% YoY to Rs 1.63 trillion, driven by healthy customer additions and strong demand, highlights IDBI Capital.
Indegene Shares In Focus As IDBI Capital Initiates Coverage — Check Target Price, Upside And MoreThe brokerag highlighted that Indegene is the only listed, pure-play life sciences commercialisation company at scale, with global rivals like EVERSANA and Syneos, and its 18%+ earnings growth comfortably supporting a valuation toward the lower-middle end of Indian IT-services peer range.
Birlasoft Still Finding Its Footing, Says IDBI Capital; Downgrades Rating After Q1 Results — Check Revised Target PriceBirlasoft's revenue grew a modest 0.3% CC QoQ, with dollar revenue flattish at $145.2 million, a marked contrast to peers like Coforge which posted double-digit growth, adds the brokerage.
Coforge Gets A Double Boost After Q1: IDBI Capital Upgrades Rating, Raises Target Price — What's Driving the Bullish Call?Coforge's confident commentary on Q2 deal pipeline, AI-led "Enterprise Autonomy" positioning (Coforge Neuron platform), and 86% revenue contribution from AI/engineering/cloud services strengthens the structural growth narrative, adds the brokerage.